z-logo
open-access-imgOpen Access
<p>Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles – Formulation and Pharmacodynamic Assessment</p>
Author(s) -
Randa Hanie Awadeen,
Mariza Fouad Boughdady,
Mahasen Mohamed Meshali
Publication year - 2020
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s274352
Subject(s) - guar gum , sonication , chitosan , materials science , particle size , bioavailability , zolmitriptan , factorial experiment , pharmacodynamics , zeta potential , gelatin , pectin , nanoparticle , chromatography , chemistry , chemical engineering , pharmacology , pharmacokinetics , nanotechnology , biochemistry , medicine , mathematics , agonist , statistics , receptor , sumatriptan , engineering
Zolmitriptan (ZT) is a selective serotonin agonist that is used for the treatment of migraine. It belongs to BCS class III with high solubility and low permeability. Besides, the drug is subjected to pre-systemic metabolism. Accordingly, new Zolmitriptan/chitosan nanostructured lipid carriers (ZT/CT NLCs) coated with Tween 80 (stealthy layer) have been developed to overcome such demerits.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here